Get started
222

MICO BIOMED CO., LTD.

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

214610 chart


Full chart

Key stats


Market capitalization
‪61.25 B‬ KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−689 KRW
Net income (FY)
‪−25.77 B‬ KRW
Revenue (FY)
‪5.37 B‬ KRW
Shares float
‪30.80 M‬
Beta (1Y)
0.48

Employees


Employees (FY)
93
Change (1Y)
−7 −7.00%
Revenue / Employee (1Y)
‪44.32 K‬ KRW
Net income / Employee (1Y)
‪−212.85 K‬ KRW

About MICO BIOMED CO., LTD.


Sector
Health Technology
Industry
Medical Specialties
CEO
Sung-Woo Kim
Website
micobiomed.com
Headquarters
Seongnam-si
Founded
2009
ISIN
KR7214610008
FIGI
BBG009DXNQ82
MiCo BioMed Co. Ltd. engages in the development, manufacture and sale of in vitro diagnosis medical devices and diagnostic reagents. It operates through the following business divisions: Molecular Diagnosis, Biochemical Diagnosis, and Immunity Diagnosis business divisions. The Molecular diagnosis business division engages in the production of nuclear acid extraction and real-time polymerase chain reaction instrument, reagents, and lab on a chip. The Biochemical diagnosis business division engages in the production of combine diagnostic equipment, anemia measuring instrument, blood glucose measuring equipment, and others. The company was founded on March 6, 2009 and is headquartered in Seongnam-si, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 214610 is 1,344 KRW — it has decreased by −2.10% in the past 24 hours. Watch MICO BIOMED CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange MICO BIOMED CO., LTD. stocks are traded under the ticker 214610.
214610 stock has risen by 2.12% compared to the previous week, the month change is a −32.21% fall, over the last year MICO BIOMED CO., LTD. has showed a −52.84% decrease.
214610 reached its all-time high on Jun 24, 2022 with the price of 14,613 KRW, and its all-time low was 1,132 KRW and was reached on Aug 5, 2024. View more price dynamics on 214610 chart.
See other stocks reaching their highest and lowest prices.
214610 stock is 3.80% volatile and has beta coefficient of 0.48. Track MICO BIOMED CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is MICO BIOMED CO., LTD. there?
Today MICO BIOMED CO., LTD. has the market capitalization of ‪61.24 B‬, it has increased by 6.92% over the last week.
Yes, you can track MICO BIOMED CO., LTD. financials in yearly and quarterly reports right on TradingView.
214610 net income for the last quarter is ‪−6.13 B‬ KRW, while the quarter before that showed ‪−7.23 B‬ KRW of net income which accounts for 15.18% change. Track more MICO BIOMED CO., LTD. financial stats to get the full picture.
No, 214610 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 93.00 employees. See our rating of the largest employees — is MICO BIOMED CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MICO BIOMED CO., LTD. EBITDA is ‪−24.16 B‬ KRW, and current EBITDA margin is −334.15%. See more stats in MICO BIOMED CO., LTD. financial statements.
Like other stocks, 214610 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MICO BIOMED CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MICO BIOMED CO., LTD. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MICO BIOMED CO., LTD. stock shows the sell signal. See more of MICO BIOMED CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.